AAAAAA
Results:
1-7
|
Results: 7
Authors:
Koshiyama, M
Morita, Y
Fujii, H
Kobashi, Y
Yoshida, M
Citation: M. Koshiyama et al., Gynecologic malignancies accompanied by benign hormone-dependent diseases, MENOPAUSE, 8(2), 2001, pp. 149-150
Authors:
Koshiyama, M
Fujii, H
Kinezaki, M
Morita, Y
Nanno, H
Yoshida, M
Citation: M. Koshiyama et al., Immunohistochemical expression of topoisomerase II alpha (Topo II alpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas, ANTICANC R, 21(4B), 2001, pp. 2925-2932
Authors:
Koshiyama, M
Fujii, H
Kinezaki, M
Yoshida, M
Citation: M. Koshiyama et al., Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas, ANTICANC R, 21(2A), 2001, pp. 905-910
Authors:
Koshiyama, M
Fujii, H
Kinezaki, M
Ohgi, S
Konishi, M
Hidetaka, N
Hayashi, M
Yoshida, M
Citation: M. Koshiyama et al., Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrialcarcinomas: a comparison with cisplatin, ANTICANC R, 20(3A), 2000, pp. 1353-1358
Authors:
Koshiyama, M
Yoshida, M
Fujii, H
Nanno, H
Hayashi, M
Tauchi, K
Kaji, Y
Citation: M. Koshiyama et al., Ovarian actinomycosis complicated by diabetes mellitus simulating an advanced ovarian carcinoma, EUR J OB GY, 87(1), 1999, pp. 95-99
Authors:
Koshiyama, M
Fujii, H
Konishi, M
Nanno, H
Hayashi, M
Tauchi, K
Yoshida, M
Citation: M. Koshiyama et al., Recurrent clear cell carcinoma of the ovary changing into producing parathyroid hormone-related protein (PTH-rP) with hypercalcemia, EUR J OB GY, 82(2), 1999, pp. 227-229
Authors:
Koshiyama, M
Konishi, I
Fujii, S
Citation: M. Koshiyama et al., Pathology, hormonal aspects, and molecular genetics of the two types of endometrial cancer, CANC J, 11(6), 1998, pp. 277-283
Risultati:
1-7
|